Today was a significant day in the field of global healthcare and an acknowledgment of the tremendous strides that Indian healthcare has taken in making life-saving cancer treatment widely available to the masses through the use of generic medicines.
It saw 21 participants from countries spanning the globe to come together at FMRI for a Preceptorship Program chaired by Dr. Rahul Bhargava, Director Hemato-Oncology and Bone Marrow Transplant, under the aegis of PACE initiative.
The participating doctors who are leaders of the medical fraternity in their respective countries were on a collaborative tour to India to observe how generic medicines are changing the landscape of cancer treatment in India.
Dr. Bhargava highlighted the importance of the program and said that no country, regardless of its economic affluence was in a position to provide the ideal cancer treatment to its citizens due to limited healthcare budgets and the escalating cost of cancer drugs.
According to him, Indian healthcare has already taken great strides towards bringing quality healthcare through generic medicines Other countries could take back valuable lessons from India’s achievements and use the knowledge attained in this program to improve their own healthcare systems.